[1] SARAN R, LI Y, ROBINSON B,et al. US renal data system 2015 annual data report: epidemiology of kidney disease in the United States[J]. Am J Kidney Dis,2016,67(3 Suppl 1): S1-S305.
[2] 王鹏, 陈康寅. 慢性肾脏病所致心脏性猝死机制的研究进展[J]. 中国心血管杂志, 2020, 25(6):595-598.
[3] GENOVESI S, BORIANI G, COVIC A,et al. Sudden cardiac death in dialysis patients: different causes and management strategies[J]. Nephrol Dial Transplant,2021,36(3):396-405.
[4] CHOW K M, SZETO C C, KWAN B C,et al. Factors associated with sudden death in peritoneal dialysis patients[J]. Perit Dial Int,2009,29(1):58-63.
[5] PUN P H, SMARZ T R, HONEYCUTT E F,et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease[J]. Kidney Int,2009,76(6):652-658.
[6] DI LULLO L, RIVERA R, BARBERA V,et al. Sudden cardiac death and chronic kidney disease: from pathophysiology to treatment strategies[J]. Int J Cardio,2016,217:16-27.
[7] 赵艳, 曾文笑, 李宓,等. 维持性血液透析患者猝死相关因素的分析[J].实用医学杂志,2014,30(3):428-431.
[8] HIYAMUTA H, TANAKA S, TANIGUCHI M,et al. The incidence and associated factors of sudden death in patients on hemodialysis: 10-year outcome of the Q-Cohort Study[J]. J Atheroscler Thromb,2020,27(4):306-318.
[9] GENOVESI S, VALSECCHI M G, ROSSI E,et al. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients[J]. Nephrol Dial Transplant,2009,24(8):2529-2536.
[10] RAMESH S, ZALUCKY A, HEMMELGARN B R,et al. Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis[J]. BMC Nephrol,2016,17(1):78.
[11] SHASTRI S, TANGRI N, TIGHIOUART H,et al. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study[J]. Clin J Am Soc Nephrol,2012,7(1):123-130.
[12] KIM E D, PAREKH R S. Calcium and sudden cardiac death in end-stage renal disease[J].Semin Dial,2015,28(6):624-635.
[13] GROMADZINSKI L, JANUSZKO-GIERGIIELEWICZ B, PRUSZCZYK P. Hypocalcemia is related to left ventricular diastolic dysfunction in patients with chronic kidney disease[J]. J Cardiol,2014,63(3):198-204.
[14] YARMOHAMMADI H, UY-EVANADO A, REINIER K,et al. Serum calcium and risk of sudden cardiac arrest in the general population[J]. Mayo Clin Proc,2017,92(10):1479-1485.
[15] SACHER F, JESEL L, BORNI-DUVAL C,et al. Cardiac rhythm disturbances in hemodialysis patients: early detection using an implantable loop recorder and correlation with biological and dialysis parameters[J]. JACC Clin Electrophysiol,2018,4(3):397-408.
[16] PAOLETTI E, SPECCHIA C, DI MAIO G,et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey[J]. Nephrol Dial Transplant,2004,19(7):1829-1834.
[17] ARIMA H, KUBO M, YONEMOTO K,et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study[J]. Arterioscler Thromb Vasc Biol,2008,28(7):1385-1391.
[18] ITO R, KUMADA Y, IAHII H,et al. Clinical outcomes after isolated infrapopliteal revascularization in hemodialysis patients with critical limb ischemia: endovascular therapy versus bypass surgery[J]. J Atheroscler Thromb,2018,25(9):799-807.
[19] 魏萌, 魏丽敏, 王萌. 维持性血液透析患者血管钙化的危险因素分析[J].中国血液净化,2020,19(11):742-746.
[20] ELHUSSEINI D, BOULANGER M C, FOUNIER D,et al. High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1[J]. PLoS One,2013,8(1):e53393.
[21] FAUL C, AMARAL A P, OSKOUEI B,et al. FGF23 induces left ventricular hypertrophy[J]. J Clin Invest,2011,121(11):4393-4408.
[22] MOE S M, CHERTOW G M, PARFREY P S,et al. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) Trial[J]. Circulation,2015,132(1):27-39. |
